Post by
Noteable on Sep 02, 2024 12:59pm
Sanofi Phase 3 drug stumbles but still filing for approval
September 02, 2024 - Sanofi is still set on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, executives have told Fierce Biotech, despite the BTK inhibitor falling short in two of three phase 3 trials that read out Monday.
https://www.fiercebiotech.com/biotech/sanofis-tolebrutinib-fails-2-trio-phase-3-ms-trials-pharma-still-plans-fda-filing